Career Enhancement Program

职业提升计划

• 批准号: 10268748
• 负责人: Jessie Villanueva
• 金额: $ 8.51万
• 依托单位: WISTAR INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-03 至 2026-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10268748
• 关键词: Acral Lentiginous Malignant Melanoma; Address; Awareness; Basal Cell Cancer; Cancer Center; Cancer Research Project; Career Mobility; Clinical; Cutaneous Melanoma; Department chair; Development; Ensure; Faculty; Financial Support; Fostering; Foundations; Funding; Funding Agency; Future; Goals; Grant; Institutes; Laboratories; Leadership; Measures; Melanoma Cell; Mentors; Mentorship; Minority; Monitor; Oral; Outcome; Paper; Peer Review; Pennsylvania; Policies; Positioning Attribute; Procedures; Progress Reports; Publications; Publishing; Research; Research Personnel; Research Project Grants; Resources; Skin Cancer; Solid; Squamous Cell; Talents; The Wistar Institute; Training; Training Support; Translational Research; Underrepresented Minority; Universities; Woman; Work; anticancer research; cancer subtypes; career; career development; diversity and inclusion; expectation; health disparity; high standard; innovation; interest; investigator training; meetings; melanoma; member; next generation; programs; recruit; research and development; success; translational cancer research; translational research program; translational scientist

Project Summary – Career Enhancement Program The goal of the Career Enhancement Program (CEP) is to recruit, train and retain a diverse pool of outstanding early-career investigators who are committed to pursuing translational skin cancer research. The CEP will be led by two established investigators with complementary expertise in basic (Dr. Villanueva) and clinical (Dr. Schuchter) melanoma research. Both co-Directors are committed to training and mentoring of translational investigators and have an established record of recruiting and supporting women and minorities. The CEP will primarily assist junior faculty in their career development, but more established investigators interested in refocusing their research efforts on melanoma/skin cancer could also be considered. Women and underrepresented minorities will be strongly encouraged to participate. Likewise, projects aimed at addressing health disparities and/or skin cancer subtypes more common in underrepresented minorities will be encouraged and given special consideration. A team of clinicians, educators and researchers with broad expertise in translational research will ensure implementation of the specific aims of this program. With the support of the University of Pennsylvania, the Abramson Cancer Center and The Wistar Institute, the CEP will provide junior faculty the resources and guidance needed to establish innovative and fully funded independent skin cancer research programs and become future academic leaders. The CEP will provide awardees with two years of financial support for translational research projects in skin cancer with potential promotion to full SPORE projects or independent grant support. Awardees are required to actively participate in SPORE functions, use the SPORE Core resources, and provide both formal written progress reports and oral presentations. We have established high standards and expectations for the research mentors and a formalized program of long-term awardee mentorship. The program measures success by resulting publications, funding, and ultimately career advancement and national recognition. We have an outstanding talent pool of candidates and an effective training and mentorship program that will result in an exceptional group of skin cancer researchers. Our SPORE CEP has had an outstanding record recruiting and training investigators for careers in translational skin cancer research. Our past CEP awardees have published 74 papers during the past cycle and have been highly successful in obtaining peer reviewed funding from NCI and/or other funding agencies. In addition, all past awardees have transitioned from young investigators into leading academic positions and remain in the skin cancer field.

项目摘要 – 职业提升计划 职业提升计划 (CEP) 的目标是招募、培训和留住多元化的优秀人才 致力于转化皮肤癌研究的早期职业研究人员。 CEP将由 由两位在基础（Villanueva 博士）和临床（Villanueva 博士）方面具有互补专业知识的资深研究人员组成。 Schuchter）黑色素瘤研究。两位联合董事都致力于翻译培训和指导 调查员，并拥有招募和支持妇女和少数族裔的既定记录。 CEP 将 主要协助初级教师的职业发展，但更有兴趣的资深研究人员 还可以考虑将他们的研究工作重新集中在黑色素瘤/皮肤癌上。妇女和 将大力鼓励代表性不足的少数群体参与。同样，旨在解决 将鼓励在代表性不足的少数群体中更常见的健康差异和/或皮肤癌亚型 并给予特别考虑。由具有广泛专业知识的临床医生、教育工作者和研究人员组成的团队 转化研究将确保该计划具体目标的实现。在以下人士的支持下 宾夕法尼亚大学、艾布拉姆森癌症中心和威斯塔研究所，CEP 将提供初级 教授建立创新且资金充足的独立皮肤癌所需的资源和指导 研究计划并成为未来的学术领袖。 CEP 将为获奖者提供两年的学习机会 为皮肤癌转化研究项目提供财政支持，并有可能推广到完整的 SPORE 项目 或独立拨款支持。获奖者需要积极参与 SPORE 功能，使用 SPORE 核心资源，并提供正式的书面进度报告和口头演示。我们已经建立了 对研究导师的高标准和期望以及长期获奖者的正式计划 指导。该计划通过所产生的出版物、资金和最终的职业来衡量成功 进步和国家认可。我们拥有优秀的候选人人才库和高效的 培训和指导计划将培养出一批杰出的皮肤癌研究人员。我们的孢子 CEP 在招募和培训转化皮肤癌研究人员方面有着出色的记录。 我们过去的 CEP 获奖者在过去的周期中发表了 74 篇论文，并非常成功地获得了 来自 NCI 和/或其他资助机构的同行评审资助。此外，所有过去的获奖者都已从 年轻的研究人员进入领先的学术职位并留在皮肤癌领域。